Why the study?
Do thromboembolic prophylaxis agents reduce the risk of deep venous thrombosis and pulmonary embolism in patients undergoing elective total hip arthroplasty?
Population
10,929 patients undergoing elective total hip arthroplasty across 52 randomized controlled trials. Inclusion…
Comparison
Thromboembolic prophylaxis agents vs Placebo or any other prophylactic agent
Design
Meta-analysis
Authors
Loading...
Supports routine prophylaxis to reduce DVT after elective THA; confirms efficacy versus placebo across agents.
Do thromboembolic prophylaxis agents reduce the risk of deep venous thrombosis and pulmonary embolism in patients undergoing elective total hip arthroplasty?
Warfarin and pneumatic compression offer the best balance of efficacy and safety for thromboembolic prophylaxis following elective total hip arthroplasty, while low-dose heparin is the least effective and safe.
Freedman et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: